The integrated R&D platform comprises more than 40 core technological sub-platforms, covering innovative antibody drug discovery, innovative antibody drug optimization, production cell line construction, upstream and downstream process development, preclinical R&D and industrial development, etc.
Apexon will focus its hiring efforts across horizontal as well as vertical expertise. The newly merged entity is expanding its MedTech and Healthcare solution offering.
The robust research and innovation ecosystem of the Healthcare & Life Sciences sector is spurring growth, and propelling demand for talent in fields like digital health, molecular diagnostics and laboratory medicine.
Owing to the rise of artificial intelligence, IoT, and Big Data in healthcare, the region’s digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent. As such, Healthcare Triangle’s entry into the region couldn’t be timelier.
TaCa Healthcare plans to invest $12-15 million (approximately Rs. 100-120 crore) in next 12-18 months to upgrade existing healthcare facilities in Tier 2 & 3 cities and up-skilling surgeons.